AlphAIalphai — Financial news for AI agents
financialcontent.comAUG 24 min read$UFPT

Earnings To Watch: UFP Technologies (UFPT) Reports Q2 Results Tomorrow

UFP Technologies (NASDAQ: UFPT) will report Q2 results Monday after market hours. The company previously reported $154.2 million revenue, up 4.1% year on year, and beat EPS estimates. For the upcoming quarter, analysts expect revenue growth of 5.4% year on year. UFPT shares are down 6.3% over the past month, with an average price target of $324.50 versus $254.78.

Original reporting
financialcontent.com
Published Aug 2, 2026, 4:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 2, 2026, 5:08 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Earnings To Watch: UFP Technologies (UFPT) Reports Q2 Results Tomorrow — source image
Source · financialcontent.com
Decision brief

The 30-second read

$UFPTNeutralMed
01

Why it matters

Traders can use the provided consensus revenue growth (5.4% YoY) versus last year (37.2% YoY) and the stock’s recent underperformance (down 6.3% over a month) to frame earnings risk and potential volatility into the print.

02

Market read

This is a pre-earnings setup for UFPT with consensus revenue growth slowing and recent stock weakness, plus peer read-across from Fortrea and Medpace.

03

What to watch

The article notes multiple recent revenue misses but does not detail margins, backlog, or guidance specifics, which are often the true drivers of post-earnings repricing.

Relevance 5/10Novelty 4/10Timing: ahead of Monday after-hours earnings release

Background

UFP Technologies is scheduled to report Q2 results after market hours Monday; the article summarizes last quarter’s revenue/EPS performance and current consensus expectations.

Company-level read

Ticker impact

$UFPTNeutralMedium confidence
Context

UFP Technologies reports Q2 results after the close Monday, with consensus revenue growth expected to slow to 5.4% YoY.

Expected impact

Likely volatility around the after-hours print, with direction dependent on whether revenue growth re-accelerates versus the 5.4% YoY expectation.

Evidence & confidence

The article provides the upcoming earnings timing and key consensus expectations, but it does not disclose new post-close results, guidance, or a fresh company-specific development beyond the preview.

Market effects

Sector

Peers’ mixed Q2 outcomes (Fortrea down, Medpace up) may influence read-across expectations for drug development inputs and services.

Regional

None specified.

Global

None specified.

Counterpoint

What could challenge this read

Despite slowing revenue growth expectations, the company’s prior EPS beat and peer dispersion could mean the market is underpricing the probability of another EPS upside surprise.

Key entities

  • company
    UFP Technologies

    Medical products company scheduled to report Q2 results after the close Monday.

  • company
    Fortrea

    Peer that reported Q2 revenues down 4.5% YoY and traded down 7.8% after results.

  • company
    Medpace

    Peer that reported Q2 revenues up 17.2% YoY and traded up 14.7% after results.

Read at source← All news

Related articles

AUG 6
$UFPTMedAI 8/10

Why UFP Technologies Stock Is Skyrocketing Today

UFP Technologies (NASDAQ: UFPT) shares rose about 24% by 2 p.m. ET after the company reported strong Q2 results. UFP said sales grew 15%, adjusted EPS rose 17%, and revenue increased 15% to its five largest customers. The company also reported 12% organic growth and 20% growth in its core medtech unit, and is monitoring tuck-in acquisitions.

yahoo.com4 min
AUG 4
$UFPTMedAI 8/10

Why Is UFP Technologies (UFPT) Stock Soaring Today

UFP Technologies (UFPT) shares rose 18.5% after the company reported Q2 2026 results that beat Wall Street. Revenue increased 15.1% to $174 million, adjusted EPS was $2.92 versus $2.56 expected, and adjusted EBITDA was $36.39 million, 11.5% above forecasts, according to the company.

financialcontent.com3 min
AUG 8
$LEEMed

Lee Enterprises, Incorporated Q3 2026 Earnings Call Summary

Lee Enterprises reported Q3 2026 progress toward a digital-first model, saying digital revenue was 57% of total revenue. It cited a 15% cash cost reduction and fifth straight quarter of comparable adjusted EBITDA growth, raising full-year adjusted EBITDA guidance to 22% to 28%. The company expects about $18M annual interest savings, positive net income of $5.2M, and plans debt paydown using excess cash and non-core asset sales.

yahoo.com6 min
AUG 8
$LNGMed

Cheniere Energy, Inc. Q2 2026 Earnings Call Summary

Cheniere Energy’s Q2 2026 call cited production outperformance and faster Corpus Christi Stage 3 startup for a second guidance raise. Full-year 2026 adjusted EBITDA guidance was revised to $7.9B-$8.4B. Management expects Sabine Pass Phase 1 FID by early 2027, targets dividend growth of at least 10% annually, and issued $1.75B dual-tranche bonds extending maturities to 2056.

yahoo.com6 min
AUG 8
$MARAMed

Marathon Digital Holdings, Inc. Q2 2026 Earnings Call Summary

Marathon Digital Holdings (MARA) discussed its Q2 2026 shift from Bitcoin mining to power-centric AI infrastructure. Management said it aims to expand energized power capacity to 4.8 GW via Matagorda and the pending Long Ridge deal, projected to add about $144 million annualized EBITDA. MARA reported a $611 million net loss, including a $343 million unrealized fair value adjustment tied to a 28% lower Bitcoin average price.

yahoo.com6 min